Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hidetoshi Horibe is active.

Publication


Featured researches published by Hidetoshi Horibe.


Journal of Controlled Release | 1993

Novel oral controlled-release microspheres using polyglycerol esters of fatty acids

Yohko Akiyama; Minoru Yoshioka; Hidetoshi Horibe; Shin-Ichiro Hirai; Nobuyuki Kitamori; Hajime Toguchi

Abstract A novel oral controlled-release drug delivery system which consists of microspheres of 75–500 μm in diameter has been designed and developed. A drug is dispersed in a spherical micromatrix of poly-glycerol esters of fatty acids (PGEFs). The microspheres were prepared by a spray-chilling method using a rotating disc and had a narrow particle size distribution. A required size could easily be obtained by altering the spray conditions. In the in vitro dissolution tests, drug release was found to be affected by the size of the microspheres and the drug content in the microspheres. However, release of the drug could be regulated by selecting an appropriate hydrophile-lipophile balance value of PGEF. PGEF-based micromatrix system could provide stable controlled release, i.e., the surface morphology and the release profiles did not change during a long storage period at 40°C while the surface morphology and the release profiles changed after only one-day storage at 40°C when hydrogenated cotton seed oil (HSCS) was used as the matrix base.


Journal of Pharmacy and Pharmacology | 1994

Anti-hypertensive effect of oral controlled-release microspheres containing an ACE inhibitor (Delapril hydrochloride) in rats

Yohko Akiyama; Minoru Yoshioka; Hidetoshi Horibe; Yoshiyuki Inada; Shin-Ichiro Hirai; Nobuyuki Kitamori; Hajime Toguchi

Abstract— An oral controlled‐release drug delivery system based on microspheres of polyglycerol esters of fatty acids (PGEFs), was applied to an anti‐hypertensive, delapril hydrochloride. The in‐vitro release profile was controlled by selecting a PGEF with an appropriate hydrophilic‐lipophilic balance value for the matrix. The microspheres from which 80% of the drug was released in 6 h were orally administered to rats. The plasma concentration of the active metabolite was sustained after administration of the microspheres in comparison with administration of a solution. The in‐vivo release profile was in good agreement with the in‐vitro release profile. When the microspheres were administered, the pharmacological effect of delapril hydrochloride on the angiotensin I‐induced pressor response was also sustained showing consistency with the plasma concentration‐time curve.


Archive | 1995

Sustained release preparations

Yohko Akiyama; Hidetoshi Horibe; Minoru Yoshioka


Archive | 1991

Granulated preparations and method of producing the same

Minoru Yoshioka; Hidetoshi Horibe; Toshio Kashihara


Archive | 1989

Controlled release preparations

Yohko Akiyama; Hidetoshi Horibe; Minoru Yoshioka


Chemical & Pharmaceutical Bulletin | 2008

Stability and stabilization studies of TAK-599 (Ceftaroline Fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825.

Yukihiro Ikeda; Junko Ban; Tomoyasu Ishikawa; Shohei Hashiguchi; Shinichi Urayama; Hidetoshi Horibe


Journal of Pharmaceutical Sciences | 1994

pH‐Independent Controlled‐Release Microspheres Using Polyglycerol Esters of Fatty Acids

Yohko Akiyama; Minoru Yoshioka; Hidetoshi Horibe; Shin-Ichiro Hirai; Nobuyuki Kitamori; Hajime Toguchi


Archive | 1989

Agent with release-controlled matrix

Yoko Akiyama; Hidetoshi Horibe; Minoru Yoshioka


Archive | 1991

GRANULATED MATTER AND PRODUCTION THEREOF

Hidetoshi Horibe; Toshio Kashiwabara; Minoru Yoshioka; 稔 吉岡; 秀俊 堀部; 俊夫 柏原


Archive | 1999

Antimycotic agent composition

Hidetoshi Horibe; Masao Nagao; Yoko Nishida; 秀俊 堀部; 陽子 西田; 将男 長尾

Collaboration


Dive into the Hidetoshi Horibe's collaboration.

Top Co-Authors

Avatar

Minoru Yoshioka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yohko Akiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toshio Kashihara

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hajime Toguchi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masao Nagao

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Kitamori

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shin-Ichiro Hirai

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoko Nishida

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Junko Ban

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shinichi Urayama

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge